Stock Scorecard
Stock Summary for Quest Diagnostics Inc (DGX) - $174.49 as of 5/13/2025 8:28:03 PM EST
Total Score
14 out of 30
Safety Score
67 out of 100
Currently on the following lists
None
Tim's Recommendation
Possible Buy
Growth List Algorithm Criteria for DGX
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for DGX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for DGX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for DGX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for DGX (67 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 7 |
| Book Value (Max of 10) | 9 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 4 |
| Operating Margin (Max of 10) | 3 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 7 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for DGX
Financial Details for DGX
Company Overview |
|
|---|---|
| Ticker | DGX |
| Company Name | Quest Diagnostics Inc |
| Country | USA |
| Description | Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe. |
| Sector Name | LIFE SCIENCES |
| Industry Name | SERVICES-MEDICAL LABORATORIES |
| Most Recent Quarter | 3/31/2025 |
| Next Earnings Date | 7/21/2025 |
Stock Price History |
|
| Last Day Price | 174.49 |
| Price 4 Years Ago | 161.17 |
| Last Day Price Updated | 5/13/2025 8:28:03 PM EST |
| Last Day Volume | 1,169,271 |
| Average Daily Volume | 1,509,695 |
| 52-Week High | 179.32 |
| 52-Week Low | 132.78 |
| Last Price to 52 Week Low | 31.41% |
Valuation Measures |
|
| Trailing PE | 22.37 |
| Industry PE | 266.29 |
| Sector PE | 49.22 |
| 5-Year Average PE | 26.92 |
| Free Cash Flow Ratio | 103.86 |
| Industry Free Cash Flow Ratio | 32.03 |
| Sector Free Cash Flow Ratio | 31.82 |
| Current Ratio Most Recent Quarter | 1.44 |
| Total Cash Per Share | 1.68 |
| Book Value Per Share Most Recent Quarter | 61.87 |
| Price to Book Ratio | 2.85 |
| Industry Price to Book Ratio | 2.47 |
| Sector Price to Book Ratio | 30.58 |
| Price to Sales Ratio Twelve Trailing Months | 1.95 |
| Industry Price to Sales Ratio Twelve Trailing Months | 2.36 |
| Sector Price to Sales Ratio Twelve Trailing Months | 25.54 |
| Analyst Buy Ratings | 8 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 111,635,000 |
| Market Capitalization | 19,479,191,150 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 4/7/2025 |
| Previous Dividend Amount | 0.7500 |
| Current Dividend Amount | 0.8000 |
| Total Years Dividend Increasing |
|
| Trailing Annual Dividend Rate | 3.05 |
| Trailing Annual Dividend Yield | 1.72% |
| Forward Annual Dividend Rate | 3.20 |
| Forward Annual Dividend Yield | 1.81% |
| 5-Year Dividend Payments Count | 20 |
| 3-Year Average Dividend Yield | 1.98% |
| 5-Year Average Dividend Yield | 1.83% |
| 1-Year Dividend Growth Rate Percentage | 8.11% |
| 3-Year Dividend Growth Rate Percentage | 3.98% |
| 5-Year Dividend Growth Rate Percentage | 7.23% |
| All-Time Dividend Growth Rate Percentage | 10.88% |
| Dividend Payout Ratio | 38.56% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 12.80% |
| Annual Earnings Growth | 1.99% |
| Reported EPS 12 Trailing Months | 7.91 |
| Reported EPS Past Year | 2.21 |
| Reported EPS Prior Year | 8.92 |
| Net Income Twelve Trailing Months | 897,000,000 |
| Net Income Past Year | 871,000,000 |
| Net Income Prior Year | 854,000,000 |
| Quarterly Revenue Growth YOY | 12.10% |
| 5-Year Revenue Growth | 5.02% |
| Operating Margin Twelve Trailing Months | 13.90% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 188,000,000 |
| Total Cash Past Year | 549,000,000 |
| Total Cash Prior Year | 686,000,000 |
| Net Cash Position Most Recent Quarter | -5,670,000,000 |
| Net Cash Position Past Year | -5,066,000,000 |
| Long Term Debt Past Year | 5,615,000,000 |
| Long Term Debt Prior Year | 4,410,000,000 |
| Total Debt Most Recent Quarter | 5,858,000,000 |
| Equity to Debt Ratio Past Year | 0.55 |
| Equity to Debt Ratio Most Recent Quarter | 0.54 |
| Total Stockholder Equity Past Year | 6,778,000,000 |
| Total Stockholder Equity Prior Year | 6,307,000,000 |
| Total Stockholder Equity Most Recent Quarter | 6,929,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 1,056,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 9.46 |
| Free Cash Flow Past Year | 909,000,000 |
| Free Cash Flow Prior Year | 864,000,000 |
Options |
|
| Put/Call Ratio | 1.55 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 2.48 |
| MACD Signal | 2.46 |
| 20-Day Bollinger Lower Band | 148.47 |
| 20-Day Bollinger Middle Band | 165.70 |
| 20-Day Bollinger Upper Band | 182.92 |
| Beta | 0.52 |
| RSI | 56.84 |
| 50-Day SMA | 155.04 |
| 150-Day SMA | 138.64 |
| 200-Day SMA | 137.63 |
System |
|
| Modified | 5/12/2025 10:09:40 PM EST |